Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (101-110 of 922) with videos related to

Pageof 93
Sort By:
Current Pharmaceutical Design|June 24, 2014
Alcohol and the cardiovascular system: a double-edged swordNiki Katsiki, Konstantinos Tziomalos, Dimitri P Mikhailidis
Current Cardiology Reports|April 13, 2026
Interrelationships Between Key Cardiovascular Risk Factors, Chronic Kidney Disease and Metabolic Dysfunction-Associated Steatotic Liver DiseaseEmir Muzurović, Ksenija Zečević, Dimitri P Mikhailidis
Expert Opinion on Investigational Drugs|November 26, 2010
Dapagliflozin: more than just another oral glucose-lowering agent?Niki Katsiki, Nikolaos Papanas, Dimitri P Mikhailidis
Current Medical Research and Opinion|September 17, 2010
Ezetimibe in diabetes: more than cholesterol lowering?Maria Sarigianni, Niki Katsiki, Dimitri P Mikhailidis
Expert Opinion on Pharmacotherapy|July 26, 2019
Lipid-lowering agents for concurrent cardiovascular and chronic kidney diseaseNiki Katsiki, Dimitri P Mikhailidis, Maciej Banach
Current Medical Research and Opinion|November 5, 2003
Early vascular benefits of statin therapyStavroula Tsiara, Moses Elisaf, Dimitri P Mikhailidis
Angiology|February 21, 2003
Apolipoprotein E polymorphism and atherosclerosisGenovefa Kolovou, Deliana Daskalova, Dimitri P Mikhailidis
Current Pharmaceutical Design|April 10, 2009
Modifying cardiovascular risk factors: newer insights and preventive measuresLuigi Landini, Aurelio Leone, Dimitri P Mikhailidis
Expert Opinion on Pharmacotherapy|December 14, 2011
Metformin and heart failure: never say never againNikolaos Papanas, Efstratios Maltezos, Dimitri P Mikhailidis
Journal of Hypertension|November 15, 2011
Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levelsNiki Katsiki, Dimitri P Mikhailidis, Maciej Banach
Pageof 93

Showing results (101-110 of 922) with videos related to

Sort By:
Pageof 93
Current Pharmaceutical Design|June 24, 2014
Alcohol and the cardiovascular system: a double-edged swordNiki Katsiki, Konstantinos Tziomalos, Dimitri P Mikhailidis
Current Cardiology Reports|April 13, 2026
Interrelationships Between Key Cardiovascular Risk Factors, Chronic Kidney Disease and Metabolic Dysfunction-Associated Steatotic Liver DiseaseEmir Muzurović, Ksenija Zečević, Dimitri P Mikhailidis
Expert Opinion on Investigational Drugs|November 26, 2010
Dapagliflozin: more than just another oral glucose-lowering agent?Niki Katsiki, Nikolaos Papanas, Dimitri P Mikhailidis
Current Medical Research and Opinion|September 17, 2010
Ezetimibe in diabetes: more than cholesterol lowering?Maria Sarigianni, Niki Katsiki, Dimitri P Mikhailidis
Expert Opinion on Pharmacotherapy|July 26, 2019
Lipid-lowering agents for concurrent cardiovascular and chronic kidney diseaseNiki Katsiki, Dimitri P Mikhailidis, Maciej Banach
Current Medical Research and Opinion|November 5, 2003
Early vascular benefits of statin therapyStavroula Tsiara, Moses Elisaf, Dimitri P Mikhailidis
Angiology|February 21, 2003
Apolipoprotein E polymorphism and atherosclerosisGenovefa Kolovou, Deliana Daskalova, Dimitri P Mikhailidis
Current Pharmaceutical Design|April 10, 2009
Modifying cardiovascular risk factors: newer insights and preventive measuresLuigi Landini, Aurelio Leone, Dimitri P Mikhailidis
Expert Opinion on Pharmacotherapy|December 14, 2011
Metformin and heart failure: never say never againNikolaos Papanas, Efstratios Maltezos, Dimitri P Mikhailidis
Journal of Hypertension|November 15, 2011
Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levelsNiki Katsiki, Dimitri P Mikhailidis, Maciej Banach
Pageof 93